These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30371199)

  • 1. Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis.
    Cavero-Redondo I; Soriano-Cano A; Álvarez-Bueno C; Cunha PG; Martínez-Hortelano JA; Garrido-Miguel M; Berlanga-Macías C; Martínez-Vizcaíno V
    J Am Heart Assoc; 2018 Sep; 7(18):e009833. PubMed ID: 30371199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence as a tool for cardiovascular risk estimation in patients with rheumatoid arthritis.
    Bakker-Aling SH; van Woerkom JM; Zomer TP; Buscher HCJL; van Bemmel T
    Eur J Intern Med; 2019 Aug; 66():e7-e8. PubMed ID: 31253386
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of non-invasive skin autofluorescence measurements with cardiovascular and all-cause mortality in hemodialysis patients: a meta-analysis.
    Varikasuvu SR; Sulekar H; Aloori S; Thangappazham B
    Int Urol Nephrol; 2020 Sep; 52(9):1757-1769. PubMed ID: 32661621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population.
    Jujić A; Östling G; Persson M; Engström G; Nilsson PM; Melander O; Magnusson M
    Diab Vasc Dis Res; 2019 Sep; 16(5):466-473. PubMed ID: 31064217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Advanced Glycation End Products in Skin Associated with Vascular Dysfunction Markers? A Meta-Analysis.
    Saz-Lara A; Álvarez-Bueno C; Martínez-Vizcaíno V; Notario-Pacheco B; Sequí-Dominguez I; Cavero-Redondo I
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32972023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.
    Kunimoto M; Yokoyama M; Shimada K; Matsubara T; Aikawa T; Ouchi S; Fukao K; Miyazaki T; Fujiwara K; Abulimiti A; Honzawa A; Shimada A; Yamamoto T; Amano A; Saitoh M; Morisawa T; Takahashi T; Daida H; Minamino T
    Cardiovasc Diabetol; 2021 Oct; 20(1):208. PubMed ID: 34656131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products via skin autofluorescence as a new biomarker for major adverse cardiovascular events: A meta-analysis of prospective studies.
    Chen Q; Huang Q; Liu W; Zhou X
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1083-1092. PubMed ID: 35260315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence and all-cause mortality in stage 3 CKD.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1361-8. PubMed ID: 24875193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
    de Vos LC; Mulder DJ; Smit AJ; Dullaart RP; Kleefstra N; Lijfering WM; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):933-8. PubMed ID: 24526694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis.
    Kimura H; Tanaka K; Kanno M; Watanabe K; Hayashi Y; Asahi K; Suzuki H; Sato K; Sakaue M; Terawaki H; Nakayama M; Miyata T; Watanabe T
    Ther Apher Dial; 2014 Oct; 18(5):461-7. PubMed ID: 24456287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease.
    Wang CC; Wang YC; Wang GJ; Shen MY; Chang YL; Liou SY; Chen HC; Lee AS; Chang KC; Chen WY; Chang CT
    Cardiovasc Diabetol; 2017 Jan; 16(1):15. PubMed ID: 28122545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
    Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
    Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes.
    Planas A; Simó-Servat O; Hernández C; Simó R
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional study.
    Yoshioka K
    Diab Vasc Dis Res; 2018 Nov; 15(6):559-566. PubMed ID: 29972075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients.
    Kunimoto M; Shimada K; Yokoyama M; Matsubara T; Aikawa T; Ouchi S; Shimizu M; Fukao K; Miyazaki T; Kadoguchi T; Fujiwara K; Abulimiti A; Honzawa A; Yamada M; Shimada A; Yamamoto T; Asai T; Amano A; Smit AJ; Daida H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):195. PubMed ID: 32326893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.